NFKB1 and breast cancer: Interestingly, increasing amounts of pseudopterosin inhibited LPS-induced NF-κB activation in NF-κB-MDA-MB-231 breast cancer cells in a concentration-dependent manner (Figure 1A) with an IC50 value of 24.4 μM.